KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer.

Noboru YamamotoMiyako SatouchiToshihiko DoiYutaka FujiwaraNoriko YanagitaniYoshitaka KawaKiyotaka YohLance LeopoldMihaela MunteanuTakashi SawadaShirong HanKazuo NoguchiMakoto Nishio

Published in: Investigational new drugs (2024)

ClinicalTrials.gov , NCT02862457.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
open label
phase ii
locally advanced
placebo controlled
clinical trial
radiation therapy
randomized controlled trial